Medical Equipment

Novel Drug Delivery Systems Industry Growth Insights: Revenue Forecast to 2030

February 9, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Novel Drug Delivery Systems Market reach by 2030 starting from 2026 levels?

The novel drug delivery systems market has experienced swift expansion in recent years. It is forecast to increase from $117.66 billion in 2025 to $129.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. The historical growth of this market can be attributed to the rising prevalence of chronic diseases, the inherent limitations of conventional drug delivery methods, the expanding pipeline of oncology and biologics, increasing healthcare expenditure, and breakthroughs in polymer and nanotechnology.

The novel drug delivery systems market size is anticipated to experience substantial expansion over the upcoming years. Its valuation is projected to reach $187.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This projected growth is driven by factors such as a rise in personalized and precision medicine, an increasing need for targeted cancer treatments, greater investment in pharmaceutical r&d, the broadening scope of biologics and biosimilars, and regulatory backing for sophisticated drug delivery innovations. Key trends anticipated during this period encompass the wider application of targeted and personalized drug delivery methods, the increasing use of lipid and polymeric nanoparticles, the development of more long-acting and controlled-release formulations, a heightened emphasis on non-invasive and patient-focused delivery pathways, and boosted r&d efforts in combination and hybrid ndds platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25850&type=smp

Which Drivers Are Influencing Long-Term Growth In The Novel Drug Delivery Systems Market?

The anticipated increase in neurological disorder cases is projected to fuel the expansion of the novel drug delivery systems market in the coming years. A neurological disorder like a stroke is a medical condition marked by an abrupt loss of neurological function, caused by an interruption in the brain’s blood supply, either due to a blockage (ischemic stroke) or a ruptured blood vessel (hemorrhagic stroke). This can lead to brain tissue damage and potentially long-term cognitive, sensory, or motor impairments. The escalating incidence of neurological disorders is primarily influenced by factors such as aging populations, the heightened prevalence of lifestyle-related conditions like hypertension, diabetes, and obesity, and increased exposure to chronic stress and environmental risk factors. Novel drug delivery systems aid in managing neurological disorders by enabling the targeted and controlled delivery of therapeutics across the blood-brain barrier. For instance, in November 2024, data from the National Health Service (NHS) England, a UK-based healthcare system, indicated that stroke admissions in England surged to 111,137 in 2023/24, with the 50–59 age group experiencing the largest increase at 12,533 cases. Thus, the growing number of neurological disorder cases is driving the growth of the novel drug delivery systems market.

Which Segments Are Driving Activity In The Novel Drug Delivery Systems Market?

The novel drug delivery systems market covered in this report is segmented –

1) By Formulation Type: Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers

2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems

3) By Route: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes

4) By Therapeutic Area: Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases

5) By End-User: Hospital, Specialty Clinics, Research Centers, Other End-Users

Subsegments:

1) By Liposomes: PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes

2) By Nanoparticles: Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals

3) By Microspheres: Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres

4) By Hydrogels: Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels

5) By Dendrimers: PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers

What Trends Are Driving The Growth Trajectory Of The Novel Drug Delivery Systems Market?

Leading companies within the novel drug delivery systems market are prioritizing the creation of innovative solutions, such as oral thin films, to improve patient adherence and therapeutic effectiveness. An oral thin film is a drug delivery method consisting of a quickly dissolving strip applied in the oral cavity, designed to release medication directly into the bloodstream through the mucosal membrane. For instance, in February 2024, CD Formulation, a US-based pharmaceutical formulation company, introduced Oral Thin Film Technology. This product facilitates rapid drug absorption by bypassing gastrointestinal and liver metabolism, making it especially suitable for patients with swallowing difficulties. It also provides accurate dosing and a faster onset of action, thereby enhancing treatment precision and convenience across various therapeutic applications.

Which Key Market Players Are Investing In Expansion And Innovation Within The Novel Drug Delivery Systems Market?

Major companies operating in the novel drug delivery systems market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche AG, Merck And Co Inc, AbbVie Inc, Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited, Catalent Inc, Evonik Industries AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/novel-drug-delivery-systems-global-market-report

Which Regions Are Projected To Dominate The Novel Drug Delivery Systems Market In The Coming Years?

North America was the largest region in the novel drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Novel Drug Delivery Systems Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25850&type=smp

Browse Through More Reports Similar to the Global Novel Drug Delivery Systems Market 2026, By The Business Research Company

Electronic Drug Delivery Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Pharmaceutical Drug Delivery Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Smart Drug Delivery Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795